Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss - CNBC

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss  CNBCLyme disease vaccine shows 70 percent efficacy, Pfizer says  The Washington PostPfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial  WSJPfizer Lyme vaccine shows more than 70% efficacy but misses key statistical goal  NBC NewsPfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial  MarketWatch